OSE Immunotherapeutics announces potential takeover under one billion euros

OSE Immunotherapeutics confirms takeover talks valued under one billion euros.

Published 2sem2 sources✓ ConfirmedNotableupdated 2sem

≈ 15sSpeed

The fact

The French biotech firm, focused on immunotherapy, draws international investors.

A firm offer could be announced by September 2026.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on June 25, 2026